Sign in

CIK 0001422142

  • Non-accelerated filer
  • Smaller reporting company

Whitehawk Therapeutics, Inc.

Sign in to watch
Ticker
WHWK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
611547850
Phone
+1 551-321-2234
Business address
2 HEADQUARTERS PLAZA, EAST BUILDING, 11TH FLOOR, MORRISTOWN, NJ, 07960
Former names
Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., ZETA ACQUISITION CORP II
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 4/A Open-market buy Director bought 1,529,402 shares at $13.08 ($19,999,990)
  5. 4 Open-market buy Director bought 259,998 shares at $13.08 ($3,399,994)
  6. 4 Open-market buy Director bought 1,529,402 shares at $13.08 ($19,999,990)
  7. 4 Grant or award Director acquired 1,911,752 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Grant or award Director acquired 7,400 shares (grant or award)
  10. 4 Grant or award Director acquired 12,334 shares (grant or award)
  11. 4 Grant or award Director acquired 6,331 shares (grant or award)
  12. 4 Grant or award Director acquired 7,811 shares (grant or award)
  13. 4 Grant or award Director acquired 8,140 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award Director acquired 8,020 shares (grant or award)
  16. 4 Grant or award Director acquired 7,290 shares (grant or award)
  17. 4 Grant or award Director acquired 6,237 shares (grant or award)
  18. 4 Grant or award Director acquired 12,151 shares (grant or award)
  19. 4 Grant or award Director acquired 7,696 shares (grant or award)
  20. 4 Derivatives Options or other derivatives

Page 8 of 14 · 263 filings